Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. (EIGRQ) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · EIGRQ · as of Jun 8, 2026
Key Statistics
Explore Eiger BioPharmaceuticals, Inc. Data
eigrq stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
eigrq competitorsEIGRQ
AVEFF
BNOEF
CRPOF
LVCLY
MGCLFStock Performance
Full HistoryAbout Eiger BioPharmaceuticals, Inc.
Eiger BioPharmaceuticals, Inc. is a commercial-stage biopharmaceutical firm dedicated to discovering and advancing treatments for critical health issues, particularly hepatitis delta virus (HDV), amon…
what is eiger biopharmaceuticals, inc. · eigrq stock overview · eiger biopharmaceuticals, inc. company profile · who is eiger biopharmaceuticals, inc. ceo · eigrq OTC · eiger biopharmaceuticals, inc. headquarters · eiger biopharmaceuticals, inc. business segments
About Stock Overview & Key Data
Eiger BioPharmaceuticals, Inc. (EIGRQ) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 30, 2014. As of the latest trading session, EIGRQ stock price is $8.50, with a market capitalization of $12.6M. The stock has returned +3.79% over the past 12 months and +20.57% year-to-date.
In fiscal year 2023, Eiger BioPharmaceuticals, Inc. reported revenue of $15.8M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Eiger BioPharmaceuticals, Inc. (EIGRQ) stock price is $8.50. The stock is traded on OTC under the ticker symbol EIGRQ. The 52-week range is $1.10 – $16.00.